Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

385
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
385
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

333
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
333
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

169
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

128
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
128
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

272
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
272
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

205
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
205

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic yield and impact on patient management from [18F]FDG-PET/CT in FUO/IUO in the adult population.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2025
Same author

Molecular Imaging in Endometrial Cancer: A Narrative Review.

Cancers·2025
Same author

Role of FDG PET/CT in bacteremia and fever of unknown origin: a pictorial overview of finding the culprit.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2025
Same author

Spondylodiscitis.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2025
Same author

The Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography in Inflammatory and Infectious Diseases: An Updated Systematic Review.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

Dual-Time-Point 18F-FDG PET/CT in Infective Endocarditis: Impact of Delayed Imaging in the Definitive Diagnosis of Endocarditis.

Biomedicines·2024

Related Experiment Video

Updated: Aug 12, 2025

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

8.3K

Molecular Imaging in Inflammatory Bowel Disease.

Edel Noriega-Álvarez1, José Martín-Comín2

  • 1Nuclear Medicine Department, University General Hospital of Ciudad Real, Ciudad Real, Spain.

Seminars in Nuclear Medicine
|January 26, 2023
PubMed
Summary

Nuclear medicine techniques like labeled leukocyte scintigraphy and PET/CT aid in managing inflammatory bowel diseases (IBD). These advanced imaging methods offer sensitive, non-invasive options for diagnosing and monitoring IBD activity and treatment response.

More Related Videos

Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.5K
Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.5K

Related Experiment Videos

Last Updated: Aug 12, 2025

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

8.3K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.5K
Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.5K

Area of Science:

  • Nuclear Medicine
  • Gastroenterology
  • Medical Imaging

Background:

  • Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease, are chronic immune-mediated gastrointestinal disorders.
  • Diagnosis typically relies on endoscopic biopsies, ultrasonography, and magnetic resonance imaging, as no single definitive test exists.
  • Nuclear medicine techniques play a complementary role in IBD management, particularly when other methods are inconclusive or unsuitable.

Purpose of the Study:

  • To review the role and advancements of nuclear medicine techniques in the diagnosis and management of inflammatory bowel diseases (IBD).
  • To highlight the utility of 99mTc-HMPAO autologous labelled leukocytes scintigraphy (WBCS) and PET/CT in assessing IBD activity, extent, and treatment response.
  • To explore the potential of emerging nuclear medicine technologies, such as PET/MR and immuno-PET, for non-invasive IBD evaluation.

Main Methods:

  • Review of nuclear medicine techniques including 99mTc-HMPAO autologous labelled leukocytes scintigraphy (WBCS) and 18F-FDG PET/CT.
  • Discussion of leukocyte labeling methods (in vitro and in vivo).
  • Exploration of current and future applications of PET/CT, PET/MR, and immuno-PET in IBD.

Main Results:

  • WBCS is highly sensitive and accurate for IBD, capable of ruling out active disease and assessing severity and treatment response.
  • 18F-FDG PET/CT demonstrates excellent sensitivity for detecting intestinal inflammation in IBD, though specificity can vary.
  • PET/CT offers more comprehensive information than PET alone for Crohn's disease evaluation, and PET is promising for non-invasive assessment, especially in children.

Conclusions:

  • Nuclear medicine techniques, particularly WBCS and PET/CT, are valuable tools in the management of IBD, offering sensitive and accurate assessment.
  • Emerging technologies like PET/MR and immuno-PET show significant promise for less invasive diagnosis and monitoring of IBD.
  • These advanced imaging modalities can complement traditional methods, providing crucial information when endoscopy or biopsies are not feasible or sufficient.